Introduction
COPD is a common, mostly preventable and treatable, chronic disease characterized by persistent airflow limitation. COPD is usually progressive and associated with an enhanced chronic inflammatory response to noxious particles or gases by the airways and alveola. 1 Exacerbations and comorbidities contribute to the overall severity. In particular, COPD-related comorbidities impact the patients' management and prognosis, especially as the airway obstruction becomes more severe. 2, 3 However, these comorbidities may be overlooked as their clinical features often overlap within one another and COPD. In this regard, the relationships between cigarette smoking and heart disease, lung cancer, and COPD are well known. 4, 5 Although prevalence data of interstitial lung abnormality (ILA) in asymptomatic smokers are increasing (largely due to the ongoing computed tomography [CT]-based lung cancer screening trials), there are scant data about the relationship between ILA and COPD. [6] [7] [8] In a study of 2,416 COPDGene participants who were cigarette smokers, ILA was found in 194 subjects (8%). The prevalence of ILA increased with age, tobacco exposure, and current smoking status. Subjects with ILA were more likely to have a restrictive lung deficit on pulmonary function tests (PFTs) and were less likely to meet Global Initiative for Chronic Obstructive Lung Disease (GOLD) criteria for COPD. 6 Since then, updates have been published for classification of fibrotic lung disease. 9, 10 Therefore, validation of relation between smoking-related ILA and COPD should be investigated in the light of the new references.
The purpose of this nested case-control study was to evaluate the association between COPD and ILAs by means of low-dose CT (LDCT), with specific focus on the radiological fibrotic pattern.
Patients and methods
Clinicoradiological data of the present study were retrieved from the databases of two studies: 1) lung cancer screening trial called Multicentric Italian Lung Detection (MILD) trial, at the Fondazione IRCCS Istituto Nazionale dei Tumori of Milan and 2) CT study on patients with COPD, at the Academic Hospital of Parma. Both studies were approved by each institutional review board (Fondazione IRCCS Istituto Nazionale Tumori di Milano and Parma, repectively), and the written informed consent was waived for the retrospective examination of the analyzed data. The study cases included all the subjects with COPD consecutively recruited in the MILD trial between September 2005 and January 2013 ( Figure 1 ). All analyses were performed using the 1:2 matched set between cases (MILD participants with airflow obstruction at baseline PFTs) and controls (MILD participants without airflow obstruction at baseline PFTs). Age (±5 years), sex, smoking status (ie, current or former smokers), and pack-years (±5) were used for matching cases to controls. MILD eligibility criteria included age 49-75 years, current or former smokers (having quit smoking within 10 years before the recruitment) with $20 pack-years of smoking history, and no history of cancer within the prior 5 years. Details of MILD trial are given elsewhere. 11, 12 Part of the LDCTs of the MILD subjects included in this study population were also analyzed by other observers in a previous study addressing a similar hypothesis. 8 Since limited subjects with severe airflow limitation were present in the MILD trial, we added clinical subjects with the aim of evaluating a broader range of COPD. All the consecutive patients with COPD who underwent both PFTs and LDCT (within 30 days of PFTs) for another study on the relationship between COPD and lung cancer at the Academic Hospital of Parma between March 2009 and December 2012 were also matched to MILD controls (as done for the MILD cases). 7, 9, 15 Definite ILA LDCT features included GGO that affected .5% of any lung zone, nondependent subpleural reticular abnormality, diffuse centrilobular nodularity with or without GGO, honeycombing, traction bronchiectasis, nonemphysematous cysts, or signs of architectural distortion (eg, fissure displacement related to any reticular abnormality). 7 Distribution prevalence was classified as follows: the upper lung zone (when most of the findings were above the level of the tracheal carina), the lower lung zone (when most of the findings were below the level of the tracheal carina), or diffuse. The definite ILA was classified into the following predominant LDCT patterns: definite usual interstitial pneumonia (UIP), possible UIP, respiratory bronchiolitis (RB), and indeterminate (Table 1) . 9, 16 Any ILA was subclassified as "fibrotic ILA" (GGO and/or intralobular reticular abnormality with traction bronchiectasis or signs of architectural distortion and honeycombing) and "nonfibrotic ILA" (GGO, centrilobular opacity, and/or reticular abnormality without traction bronchiectasis or signs of architectural distortion). 10 
statistical analysis
Comparative analysis of demographic and functional data was performed by unpaired t-test, analysis of variance (ANOVA) analysis, or a chi-square test with Fisher's exact test as 
Results
The demographic characteristics of the study subjects are summarized in Table 2 . The final study population included a total of 457 cases matched to 914 controls ( Figure 1 ). A total of 311 out of 457 (60.1%) cases were MILD participants, whereas the remainder 146 out of 457 (31.9%) cases were clinical COPD subjects consecutively recruited at the University Hospital of Parma. All subjects were white Caucasians. At the best of the multiparametric matching process, cases were older than controls (P,0.001), heavier smokers (P=0.01), and more frequently former smokers (P=0.0009). The classification of LDCT patterns is summarized in Table 3 . The definite UIP pattern was found in two out of 914 (0.2%) controls only, while the possible UIP pattern in four out of 457 (0.9%) cases ( Figure 2 ) and eight out of 914 (0.9%) controls (Figure 3 ). Signs consistent with RB were more frequent in controls (P=0.04; Figure 4 ), whereas the indeterminate pattern was more frequent in cases (P=0.006). In particular, the LDCT pattern was classified as indeterminate in 12 out of 115 (10.4%) cases with definite ILA because of either predominant ground glass opacities or predominant upper lung zone abnormalities. Individual LDCT features are summarized in Table S1 . Equivocal ILAs were observed only among cases (14 out of 457, 3%), with eight out of 14 (60%) equivocal ILAs being consistent with AEF ( Figure 5 ) and the remainder six out of 14 (40%) showing unilateral opacity. Overall, the frequency of definite ILA was similar between cases and controls (P=0.2; Table 4 ) as well as among the study subgroups (ie, COPD cases, MILD subjects with airflow obstruction, and subjects without airflow obstruction, P=0.2). This was also true for any (ie, both definite and equivocal) fibrotic ILAs between cases and controls (P=0.07). Any (ie, combined definite and indeterminate) ILA did not differ in terms of frequency across GOLD stages (P=0.6), whereas any fibrotic ILA was less frequent in controls as compared to subjects with GOLD 1, 2, 3, or U (P=0.03; Figure 6 and Table S2 ).
As compared with subjects without any ILA, those with any ILA were more frequently men, current smokers, and had a greater amount of exposure to tobacco smoke (Table 4) . At adjusted logistic regression analysis, current smoking status (OR 4.05, 95% CI: 2.2-7.4) and increasing pack-years (OR 1.01, 95% CI: 1-1.02) were factors associated with the presence of definite ILA (Table 5) . Subjects with any fibrotic ILA were more likely to be older (OR 1.17, 95% CI: 1.10-1.25) and men (OR 8.58, 95% CI: 1.58-68.9). Table 6 ). The presence of airflow obstruction was associated with neither definite ILA nor any fibrotic ILA in the adjusted models.
Discussion
In this nested case-control study, there was no association between ILA and COPD in smokers. We observed signs of definite ILA on LDCT in 7.5% of the COPD subjects. These findings are similar and add weight to the study by Washko et al 6 who reported definite ILAs in 7.3% of a large study population of GOLD 1-4 stages COPD subjects. Additionally, our study provides more detailed data about the prevalence of fibrotic ILA in COPD, namely, 2.8% in total or 0.9% when the sole definite fibrotic ILAs were considered.
In line with the study by Washko et al, 6 the presence of a definite ILA was not associated with odds of meeting COPD. Indeed, the ILA frequency was similar across GOLD 1-4 stages. Of note, no signs of ILA were observed in GOLD 4 COPD. In contrast with the findings from Washko et al, subjects with definite ILA were not likely to meet the GOLD U criteria. However, both latter observations are limited by the small number of subjects in these functional stages. Furthermore, we showed that the prevalence of definite ILAs was similar across the study subgroups, in particular between patients with symptomatic COPD and asymptomatic participants to lung cancer screening, thus strengthening the primary observation of this study. Therefore, these findings suggest that COPD is not a risk factor for ILA.
Although the lack of association between COPD and ILA is obvious on a functional basis, it is noteworthy that ILA may be missed in smokers through standard clinical-functional In two cases, unilateral reticulation and aeF coexisted. Abbreviations: lDCT, low-dose computed tomography; Ila, interstitial lung disease; UIP, usual interstitial pneumonia; n/a, not applicable; rB, respiratory bronchiolitis; AEF, airspace enlargement with fibrosis. 
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Bozzetti et al assessment, in particular for those with COPD. 17 Indeed, ILA may be mild with no effect on lung volumes. 6, 18 Furthermore, it is still not clear which proportions of emphysema and ILA are required to produce either predominant obstructive or predominant restrictive functional pattern. The broad distribution of participants with ILAs on a plot of FEV 1 % (as a percentage of the predicted value) against the ratio of FEV 1 /FVC suggests that spirometry alone is not helpful in classifying ILA in smokers ( Figure 6 ). This observation is limited by the lack of full pulmonary function data (eg, total lung capacity and residual volume) and emphysema in the present study that would have clarified the relationship between ILA and the restrictive functional pattern.
In keeping with the study by Washko et al, 6 the current smoking status was the strongest factor associated with definite ILA in the group of cases. Furthermore, in the whole study population, the positive associations with both current smoking status and higher pack-years strengthen the hypothesis that such ILAs are smoking related. This observation is particularly true considering that cases were matched to controls for smoking history.
To better understand the clinical significance of the ILA in smokers, it is important to clearly distinguish CT abnormalities that are likely to be reversible (eg, after smoking cessation) from those that are not. Washko et al 6 found definite ILA on CT images in 13.4% (89 of 660) of cigarette smokers with GOLD 1-4 COPD. Most of the abnormalities in these 
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Interstitial lung abnormalities in COPD participants were nonfibrotic, but 1.8% participants (12 of 660) met American Thoracic Society and European Respiratory Society criteria for fibrotic ILA. Overall, we reported that 2.8% of COPD subjects showed fibrotic ILAs but only 0.9% with definite fibrotic LDCT features. In particular, the definite UIP pattern was not observed in COPD cases, and its prevalence among controls was similar to that reported by prior studies. 7, 8 To our knowledge, this is the first study assessing the prevalence of the probable UIP pattern, which was similar in both cases and controls (0.9%). However, in the absence of histologic data, the estimation of the UIP prevalence is not fully reliable. In fact, the LDCT possible UIP pattern may still overlap NSIP and other mixed smokingrelated fibrotic abnormalities in smokers. 16, 19 On the other hand, unilateral reticulation -here scored as equivocal LDCT findings -may still represent unilateral UIP. 20 Importantly, we showed that male sex and age were the only factors strongly associated with the presence of fibrotic ILA. Such a finding is in keeping with prior studies, notably with the observation of Fell et al 21 in subjects with UIP.
22
This is also the first study that assessed the prevalence of the LDCT signs consistent with AEF. The histologic features of this fibrotic disorder were initially described in lung specimens obtained from major surgery. 23, 24 Corresponding CT features have been sporadically reported and acknowledged in the latest American Thoracic Society and European Respiratory Society classification of the idiopathic interstitial pneumonias.
9, 25 Watanabe et al 15 have recently suggested that AEF may be reliably distinguished from honeycombing. In keeping with their findings, signs consistent with AEF were observed either in association with other ILAs or as the predominant ILA. These abnormalities mostly predominated in the upper lobes and were more frequently observed in subjects with COPD. This relatively higher prevalence might be explained by considering that COPD subjects usually have more severe emphysema, a condition invariably associated with this kind of fibrotic abnormality.
We have also clarified that signs of RB are rarer in smokers with airflow obstruction (4.4%) as compared to smokers with no airflow obstruction (7.7%). It is likely that the relatively higher proportion of former smokers among COPD may have accounted to such a difference. In fact, smoking cessation is the most important intervention for the treatment of bronchiolitis as lesions may partially or completely reverse. Smoking cessation is also essential in emphysema to limit extension. 26 This study has several limitations. Two pairs of observers jointly reviewed two separate groups of CT scans and no interobserver variation could be evaluated. The majority of the study cases had mild-to-moderate airflow obstruction, and data on subjects with severe COPD are scant. No full functional assessment could be performed in most of the study cases, thus limiting the characterization of subjects with ILA. Furthermore, the lack of quantitative data for both pulmonary emphysema and ILA is another important limitation. Such data might clarify how lung fibrosis and emphysema interplay to determine the functional deficit of individual subjects.
Conclusion
This nested case-control study confirms that there is no association between COPD and definite ILAs. However, fibrotic abnormalities may be appreciated in smokers either with or without airflow obstruction. Future studies might clarify the importance of detecting these ancillary CT findings in COPD.
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